Patents by Inventor Toyokazu Seki

Toyokazu Seki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7838229
    Abstract: The present invention provides an identification marker responsive to IFN therapy for renal cell cancer and a means of detecting the same. Namely, a method which comprises preparing a genomic DNA of a human gene or a complementary strand thereof from a specimen of a patient with renal cell cancer, analyzing the DNA sequence of the genomic DNA or the complementary strand thereof to determine the gene polymorphism of the human gene, and evaluating the tumor-suppression effect of IFN therapy on renal cell cancer by using the polymorphism as an indicator.
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: November 23, 2010
    Assignee: Otsuka Pharmaceutical Co., Ltd.
    Inventors: Toyokazu Seki, Takayuki Shiratsuchi, Osamu Ogawa, Seiji Naito, Taiji Tsukamoto, Hiroshi Toma, Yoshihiko Hirao, Susumu Kagawa, Yoshiaki Nose, Tsuyoshi Nakamura
  • Publication number: 20080199859
    Abstract: The present invention provides an identification marker responsive to IFN therapy for renal cell cancer and a means of detecting the same. Namely, a method which comprises preparing a genomic DNA of a human gene or a complementary strand thereof from a specimen of a patient with renal cell cancer, analyzing the DNA sequence of the genomic DNA or the complementary strand thereof to determine the gene polymorphism of the human gene, and evaluating the tumor-suppression effect of IFN therapy on renal cell cancer by using the polymorphism as an indicator.
    Type: Application
    Filed: October 24, 2005
    Publication date: August 21, 2008
    Applicant: OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Toyokazu Seki, Takayuki Shiratsuchi, Osamu Ogawa, Seiji Naito, Taiji Tsukamoto, Hiroshi Toma, Yoshihiko Hirao, Susumu Kagawa, Yoshiaki Nose, Tsuyoshi Nakamura